Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942010000200007
Brazilian Journal of Anesthesiology
Scientific Article

Reperfusão rápida e homogênea como fator de risco da síndrome pós-reperfusão hepática durante transplante ortotópico de fígado

Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation

Lucas Cordoví de Armas; Rosa E. Jiménez Paneque; Boris Gala López; Edin Ismael Rápalo Romero; Ydriss Añuez Castillo; Marina Beatriz Vallongo Menéndez

Downloads: 0
Views: 712

Resumo

JUSTIFICATIVA E OBJETIVOS: A revascularização do órgão transplantado é um momento crucial no transplante ortotópico de fígado (TOF). Aproximadamente um terço dos pacientes desenvolve síndrome pós-reperfusão hepática (SPR), uma combinação de hipotermia, desordens metabólicas e instabilidade cardiovascular que podem levar à parada cardíaca. O objetivo deste estudo foi avaliar a relação velocidade-qualidade (RVQ) da reperfusão do órgão transplantado como fator independente de predição da SPR. MÉTODOS: Todos os pacientes elegíveis que se submeteram ao TOF em nossa instituição de 1987 a março de 2009 foram incluídos. O OR ajustado da associação RVQ-SPR foi obtido através do modelo de regressão logística, incluindo oito variáveis de confusão. RESULTADOS: A proporção de pacientes que desenvolveram SPR foi maior nos pacientes com RVQ identificada como boa (75,8%) do que naqueles com RVQ média ou baixa; o risco relativo ao comparar a RVQ de boa qualidade com a RVQ de baixa qualidade foi de 12,9 (IC 95%: 2,1 - 528,8). O OR ajustado foi de 132,9 (IC 95%: 10,5 - 1688,6) quando a RVQ de boa e baixa qualidade foram comparadas e de 90,9 (IC 95%: 13,8-645,2) comparando a RVQ boa com a intermediária. CONCLUSÕES: De acordo com nossos resultados, a RVQ pode ser considerada um bom fator preditivo da SPR.

Palavras-chave

CIRURGIA, Transplante, FATORES DE RISCO, REPERFUSÃO

Abstract

BACKGROUND AND OBJECTIVES: The revascularization of the graft remains as a crucial instant of the orthotopic liver transplantation (OLT) surgical procedure. About a third of the recipients suffer the postreperfusion syndrome (PRS), a combination of hypothermia, metabolic disorders and cardiovascular instability potentially leading to cardiac arrest. The objective of this study was to evaluate the speed-quality (SQR) of the graft`s reperfusion as an independent predictor of PRS. METHODS: All eligible patients receiving an OLT in our institution from 1987 to march 2009 were included. The adjusted OR for SQR-PRS association was obtained by means of logistic regression modeling including eight potential confounders. RESULTS: The proportion of recipients suffering PRS was highest when the SQR was identified as good (75.8%) compared to those with middle or poor SQR; the relative risk comparing good SQR with poor SQR was 12.9 (CI 95%: 2.1-528.8). The adjusted OR was 132.9 (95% CI: 10.5-1688.6) when comparing good with bad SQR and 90.9 (95% CI: 13.8-645.2) when comparing good with intermediate SQR. CONCLUSIONS: According to our results, SQR can be considered an unambiguous predictor of PRS.

Keywords

SURGERY, Transplantation, RISK FACTORS, REPERFUSION

References

Hoffmann K, Weigand MA, Hillebrand N. Is veno-venous bypass still needed during liver transplantation?: A review of the literature. Clin Transplant. 2009;23:1-8.

Hilmi I, Horton CN, Planinsic RM. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl. 2008;14:504-508.

Aggarwal S, Kang Y, Freeman JA. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc. 1987;19(4^s3):54-55.

Ulukaya S, Basturk B, Kılıç M. Cytokine gene polymorphism and postreperfusion syndrome during orthotopic liver transplantation. Transplant Proc. 2008;40:1290º1293.

Shi XY, Xu ZD, Xu HT. Cardiac arrest after graft reperfusion during liver transplantation. Hepatobiliary Pancreat Dis Int. 2006;5:185-189.

Ulukaya S, Alper I, Aydin U. Successful resuscitation of cardiac arrest due to postreperfusion syndrome during orthotopic liver transplantation: a case report. Transplant Proc. 2007;39:3527º3529.

Ayanoglu HO, Ulukaya S, Tokat Y. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc. 2003;35:1442-1444.

Tsinari KK, Misiakos EP, Lawand CT. Factors affecting metabolic and electrolyte changes after reperfusion in liver transplantation. Transplant Proc. 2004;36:3051-3056.

American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: Part 10.1: Life-threatening electrolyte abnormalities. Circulation. 2005;112(24^sSuppl):IV-121-125.

Puhl G, Schaser KD, Vollmar B. Non-invasive in vivo analysis of the human hepatic microcirculation using orthogonal polarization spectral (OPS) imaging. Transplantation. 2003;75:756-761.

Lisik W, Gontarczyk G, Kosieradzki M. Intraoperative blood flow measurements in organ allografts can predict postoperative function. Transplant Proc. 2007;39:371-372.

Aucejo FN, Hashimoto K, Quintini C. Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl. 2008;14:96-99.

Nanashima A, Pillay P, Crawford M. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg. 2001;8:557-563.

Puhl G, Schaser KD, Pust D. Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation. Liver Transpl. 2005;11:555-563.

Mizunuma K, Ohdan H, Tashiro H. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor. Transplantation. 2003;75:579-586.

Moreno C, Sabaté A, Figueras J. Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl. 2006;12:1607-1614.

5dd2e4330e88253228c63493 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections